Skip to content Skip to footer

International Cannabis Weekly: 313

August 25, 2023

Highlights

Share this story
Highlights


SWITZERLAND LAUNCHES ITS SECOND CANNABIS PILOT TRIAL IN ZURICH

The city of Zurich has marked a significant milestone with the official launch of its cannabis pilot trials “ZüriCan”. These trials represent a further development in the legalisation and regulation of cannabis in Switzerland.

READ MORE  »

PHARMA INDUSTRY INTEREST GROWS AS M&A ACTIVITY INCREASES

READ MORE »

MICHIGAN ON TRACK TO BECOME SECOND LARGEST CANNABIS MARKET IN THE US

READ MORE »

Highlights

Share this story
Europe
  • German cannabis group SynBiotic announces new €3 million investment, new acquisition and new CEO.
  • Cannabis Poland announces second quarter financial 2023 results, reporting 17% loss.
  • UK sees the second highest number of clinical trials carried out on cannabinoids in last decade, according to new report
  • New study in Greece finds medical cannabis improves job performance as well as having a myriad of other benefits.
  • Ukraine Health Ministry calls for relaxation of cannabis laws to facilitate medical use.
  • Pharma C receives £30k fine for Aquis rule breaches, and Akanda pays off Halo loans with stock.

Highlights

Share this story
Stocks

Highlights

Share this story
United States
  • New York’s rocky road to the rollout of its adult-use cannabis market faces another set back as injunction granted.
  • Ohio confirms it will vote on cannabis legalisation for adult-use purposes in November.
  • Alabama’s medical cannabis regulators face another lawsuit after rescinding a licence it had issued to Verano.
  • Nevada’s cannabis industry takes another step forward as four significant cannabis regulation bills are signed into law.
  • The City of Lubbock, Texas, launches initiative in a bid to decriminalise low-level cannabis possession.
  • New research shows 14 states and cities have now cut taxes to help support cannabis businesses.

Highlights

Share this story
New Report

Highlights

Share this story
Canada
  • Tilray confirms acquisition of drinks brand Truss Beverage Co. from Molson Coors Canada.
  • New report from Health Canada reveals high fees on cannabis businesses are preventing profits in the industry.
  • Toronto’s Organigram announces relaunch of one of Canada’s best known cannabis brands, Trailblazer.
  • Canopy Growth confirms sale of its facility in Ontario, back to its original owner Hershey Canada – for C$53 million.
  • Vancouver’s AgriCann announces strategic partnership agreement with Klonetics Plant Science Inc.
  • Melodiol Global Health’s subsidiary Mernova Medical on track to significantly increase its quarter-on-quarter growth.

Highlights

Share this story
Upcoming Event

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC
  • Australian study expected to be the world’s largest on the health economic impact of medical cannabis.
  • Thailand’s cannabis regulation is back on the agenda as the number of cannabis outlets continues to rise.
  • Cannabis use is a growing medicinal trend in NZ rugby, and a former All Black believes it should be embraced.
  • Releaf announces International College of Cannabinoid Medicine (ICCM) workshop dates for Australia and the UK.

Highlights

Share this story
Africa & The Middle East
  • Morocco taking effective measures to streamline cannabis cultivation for the global stage.
  • Chicago’s Seed and Beyond partners with Bpure, a leading medical cannabis grower and exporter in Africa.
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.